Back to search

Article

Efficacy of Radioiodine in Non-Distant Metastatic Papillary Thyroid Cancer with TERT-p Mutation at Initial Diagnosis

2024-12-16

Abstract excerpt

<title>Abstract</title> <p><bold>Background </bold> In patients with non-distant metastatic PTC and TERT-p mutation being a rare entity at initial diagnosis, it is unclear whether <sup>131</sup>I treatment is effective and can reduce the risk of recurrence after surgery. The objective of this study was to determine the clinical characteristics, effectiveness of radioiodine (<sup>131</sup>I), and recurrence-free s...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
adf2709f-75d3-54e6-9535-e4f2ed54036d
DOI
10.21203/rs.3.rs-5142478/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Efficacy of Radioiodine in Non-Distant Metastatic Papillary Thyroid Cancer with TERT-p Mutation at Initial DiagnosisDOI 10.21203/rs.3.rs-5142478/v1
Risk-stratified Distant Metastatic Thyroid Cancer with Clinicopathological Factors and BRAF/TERT Promoter Mutations.Semantic proximity
Non-Iodine-Avid Disease Is Highly Prevalent in Distant Metastatic Differentiated Thyroid Cancer With Papillary Histology.Semantic proximity
Genetic modification of the AJCC classification of papillary thyroid cancer: an international, multicentre, retrospective cohort study.Semantic proximity
TERT Promoter Mutations Contribute to Adverse Clinical Outcomes and Poor Prognosis in Radioiodine Refractory Differentiated Thyroid CancerSemantic proximity
Value of TERT promoter mutations for early outcomes in papillary thyroid cancer.Semantic proximity
Risk Factors for TERT Promoter Mutations with Papillary Thyroid Carcinoma Patients: A Meta-Analysis and Systematic Review.Semantic proximity
TERT promoter mutations contribute to adverse clinical outcomes and poor prognosis in radioiodine refractory differentiated thyroid cancer.Semantic proximity
Validation of the International Medullary Thyroid Carcinoma Grading System in Patients with Distant Metastases.Semantic proximity
BRAF V600E Mutation-Assisted Risk Stratification of Solitary Intrathyroidal Papillary Thyroid Cancer for Precision Treatment.Semantic proximity
Risk of second primary malignancy after radioiodine for thyroid carcinoma: a SEER-based studySemantic proximity
The Genetic Duet of BRAF V600E and TERT Promoter Mutations Robustly Predicts Loss of Radioiodine Avidity in Recurrent Papillary Thyroid CancerSemantic proximity
Prognostic Value and Therapeutic Response Prediction of BRAF, RAS, and TERT Gene Mutations in Thyroid Cancer: A Large-Scale Analysis Based on the Cosmic DatabaseSemantic proximity
Select a neighboring publication to make it the new centre.